- Home
- RCS vs OPRX Comparison
RCS vs OPRX Comparison
Compare RCS & OPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RCS | OPRX |
|---|---|---|
| Founded | 1994 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Business Services |
| Sector | Finance | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 308.9M | 272.0M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | RCS | OPRX |
|---|---|---|
| Price | $6.64 | $15.20 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $14.83 |
| AVG Volume (30 Days) | 141.1K | ★ 318.5K |
| Earning Date | 01-01-0001 | 11-06-2025 |
| Dividend Yield | ★ 10.12% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.00 |
| Revenue | N/A | ★ $109,506,000.00 |
| Revenue This Year | N/A | $17.92 |
| Revenue Next Year | N/A | $10.91 |
| P/E Ratio | ★ N/A | $8,307.94 |
| Revenue Growth | N/A | ★ 24.18 |
| 52 Week Low | $4.51 | $3.99 |
| 52 Week High | $6.31 | $22.25 |
Technical Indicators
Market Signals| Indicator | RCS | OPRX |
|---|---|---|
| Relative Strength Index (RSI) | 33.76 | 41.61 |
| Support Level | $6.52 | $15.11 |
| Resistance Level | $6.73 | $16.37 |
| Average True Range (ATR) | 0.15 | 0.77 |
| MACD | -0.03 | 0.03 |
| Stochastic Oscillator | 25.36 | 50.92 |
Price Performance
Historical ComparisonAbout RCS PIMCO Strategic Income Fund Inc.
PIMCO Strategic Income Fund, Inc. operates as a closed-end management investment company. Its primary investment objective is to generate a level of income that is higher than that generated by high-quality, intermediate-term U.S. debt securities. The Fund also seeks capital appreciation to the extent consistent with the objective.
About OPRX OptimizeRx Corporation
OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its product offerings are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement.